STAT - Reporting from the frontiers of health and medicine

Exclusive

Politics

Health Tech

Exclusive AstraZeneca Covid-19 vaccine study put on hold due to suspected adverse reaction in participant in the U.K.
Biotech Liquid biopsy startup Grail, in filing for IPO, lays out investments and plans for growth
Health How common is burnout among physicians? It depends on how it’s defined
First Opinion Coming to terms with the real bioterrorist behind Covid-19: nature
Health U.S. needs 193 million Covid-19 tests per month to reopen schools and keep up with pandemic, new report says

Daily, market-moving coverage of biotech and pharma

Inside intelligence on the NIH, the FDA, and Congress

Profiles of the power players shaping the industry

Analysis of the latest scientific developments

The Pony Express? U.S. Postal Service changes continue to slow down deliveries of mail-order prescriptions
Drug and device makers paid teaching hospitals $832 million in 2018, creating potential for conflicts of interest
A second U.S. agency will review if Moderna disclosed federal funding in vaccine patents

Special Report

Politics

Special Report

Special Report

Health Tech

By Juliet Isselbacher

Health

Exclusive AstraZeneca Covid-19 vaccine study put on hold due to suspected adverse reaction in participant in the U.K.
Exclusive Covid-19 vaccine trial participant had serious neurological symptoms, but could be discharged today, AstraZeneca CEO says
Health Covid-19 Drugs and Vaccines Tracker
Health The Covid-19 Tracker
Health Operation Warp Speed promised to do the impossible. How far has it come?
Health ‘Carnage’ in a lab dish shows how the coronavirus may damage the heart
The Pharmalot View Pharma drew a line in the sand over Covid-19 vaccine readiness — because someone had to
Health Tech Dan Trigub, head of Uber Health, is leaving to launch a health care startup